|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.79(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-11-30 |
4 |
OE |
$15.28 |
$659,001 |
D/D |
39,288 |
67,184 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-30 |
4 |
S |
$22.80 |
$547,200 |
D/D |
(24,000) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-30 |
4 |
OE |
$8.50 |
$204,000 |
D/D |
24,000 |
298,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-29 |
4 |
S |
$22.84 |
$548,088 |
D/D |
(24,000) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-29 |
4 |
OE |
$8.50 |
$204,000 |
D/D |
24,000 |
298,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-28 |
4 |
S |
$23.02 |
$552,480 |
D/D |
(24,000) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-11-28 |
4 |
OE |
$8.50 |
$204,000 |
D/D |
24,000 |
298,011 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-11-25 |
4 |
S |
$23.50 |
$208,633 |
D/D |
(8,878) |
23,540 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-11-25 |
4 |
OE |
$16.77 |
$148,884 |
D/D |
8,878 |
32,418 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-30 |
4 |
S |
$22.08 |
$779,225 |
D/D |
(35,291) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-30 |
4 |
OE |
$8.50 |
$299,974 |
D/D |
35,291 |
309,302 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-29 |
4 |
S |
$21.22 |
$355,796 |
D/D |
(16,767) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-29 |
4 |
OE |
$8.50 |
$142,520 |
D/D |
16,767 |
290,778 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-28 |
4 |
S |
$21.61 |
$369,747 |
D/D |
(17,110) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-09-28 |
4 |
OE |
$8.50 |
$145,435 |
D/D |
17,110 |
291,121 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-08-30 |
4 |
S |
$22.00 |
$62,304 |
D/D |
(2,832) |
274,011 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2016-08-30 |
4 |
OE |
$8.50 |
$24,072 |
D/D |
2,832 |
276,843 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-08-26 |
4 |
OE |
$15.71 |
$78,550 |
D/D |
5,000 |
23,540 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-09 |
4 |
S |
$22.56 |
$454,917 |
D/D |
(20,168) |
59,896 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-09 |
4 |
OE |
$17.38 |
$350,520 |
D/D |
20,168 |
80,064 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-08 |
4 |
S |
$22.73 |
$38,301 |
D/D |
(1,685) |
59,896 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-08 |
4 |
OE |
$17.38 |
$29,285 |
D/D |
1,685 |
61,581 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-05 |
4 |
S |
$23.50 |
$4,794 |
D/D |
(204) |
59,896 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2016-08-05 |
4 |
OE |
$17.38 |
$3,546 |
D/D |
204 |
60,100 |
|
- |
|
Tamerius John |
SVP, Strat & Ext Affairs |
|
2016-08-01 |
4 |
S |
$23.02 |
$161,124 |
D/D |
(7,000) |
18,540 |
|
- |
|
1127 Records found
|
|
Page 28 of 46 |
|
|